Dupilumab Effective for Children with Severe Atopic Dermatitis in Real World Setting

Dupilumab’s efficacy and safety findings among children aged 6 months to 5 years with severe atopic dermatitis are consistent with previous results observed in those with moderate-to-severe disease, new data suggest.¹

Audrey Lasek, MD, from…